OptionsHouse

Options Trading News

August 3, 2012  Fri 2:32 AM CT

ZIOP: SEE CHART GET CHAIN FIND STRATEGIES
Someone is looking for volatility to pick up in ZioPharm Oncology.

optionMONSTER's tracking systems detected the purchase of 2,469 January 5 puts for $0.80 against open interest of just 63 contracts. Several large blocks of shares were purchased shortly after, apparently creating a so-called delta-neutral trade.

Owning puts and stock at the same time makes the investor directionally neutral on the drug developer. They stand to profit, however, from implied volatility increasing because that will inflate the value of the options. Using long-dated contracts increases the sensitivity to the change because they have a higher vega. (See our Education section)

He or she is probably looking forward to results from the ongoing Phase 3 trials of ZIOP's Palifosfamide cancer drug. Option premiums often increase as the market anticipates such data, which can make or break a company's future. Implied volatility currently stands at 57 percent versus its 38 percent historical propensity to move.

The shares rose 4.29 percent to $5.59 yesterday. It reported quarterly results after the bell, but earnings usually don't matter for a development-stage companies like ZIOP.

The delta-neutral trade pushed total option volume in the name to 9 times greater than average.
Share this article with your friends


Related Stories

ZIOP

Bulls rack up quick wins in Ziopharm

January 28, 2015

The drug maker has been running hard since October, gapping higher on Jan. 14 after management announced a licensing agreement with the University of Texas MD Anderson Cancer Center.

Invest Like a Monster - Las Vegas: March 13-14

Premium Services

Archived Webinar

Option Money Machine Winter Classic

Education & Strategy

The rolling technique

In the January 7th edition of Advantage Point, we initiated the purchase of a second week-out GOOGL 535 put at...

View more education articles »